Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

education programme

Creativity has lost its worth

Creativity has lost its worth, and sadly it is undermining effectiveness

Page & Page Health

Healthcare Comms appointments

Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWAWorldHealth London sees Andy Hayley and Dick Dunford return

- PMLiVE

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on EUSA drug

News from pharma, biotech and healthcare

- PMLiVE

NHS England says yes to Roche’s Hemlibra

But stalls on funding for Actelion's Uptravi

- PMLiVE

Axovant licenses another gene therapy as new strategy beds in

Group pursues gene therapy strategy

- PMLiVE

Communiqué: big wins for obesity and sugar tax campaigners

More highlights from healthcare communications awards

- PMLiVE

Abingworth raises $315m to expand hunt for promising biotechs

New fund earmarked for early to late-stage European and US firms

Training the next generation of biotech leaders

Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy,...

Blue Latitude Health

- PMLiVE

New ABPI president pledges closer collaboration with NHS

UK pharma body appoints a president and vice president for the first time

- PMLiVE

Daily Brief: Crunch time for Brexit, GSK CEO RSVP from Trump

A round up from pharma, biotech and healthcare

Biogen Idec building

Biogen and Eisai claim mid-stage win for Alzheimer’s drug

Says drug slowed down progression of cognitive decline

- PMLiVE

UDG Healthcare acquires two New-York-based healthcare agencies

Offers a combined total of $82.4m for Create NYC and SmartAnalyst

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links